Get notified when XIII files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Only Holders of Our Class B Ordinary Shares Will Have the Right to Vote On the Appointment and Removal of Directors (new) — Public Class A shareholders have no say in director appointments before the business combination, concentrating control with the sponsor.
- Conflicts of Interest (new) — The sponsor's affiliate and its founder have fiduciary duties to other clients, which may divert acquisition opportunities away from the company.
- Litigation (new) — The CEO was a defendant in a settled stockholder lawsuit alleging disclosure failures in a prior SPAC, which could distract management and harm reputation.
- Substantial Profit (new) — The nominal cost of founder shares incentivizes insiders to complete a deal even if it harms public shareholders.
- Expire Worthless (new) — Insiders may push for a bad deal to avoid losing their founder shares and private placement units.
- No Fiduciary Duties (unchanged) — Strategic and Operating Partners have no fiduciary duty to the company, so they may not act in shareholders' best interests.
- Conflicts of Interest (new) — The sponsor and management are involved with multiple blank check companies, creating conflicts over which entity gets a deal.
- Controlled-company Status (new) — Prospectus discloses controlled-company status under exchange rules, which permits exemptions from certain independent-director and committee requirements.
Churchill Capital Corp XIII prices $360M SPAC IPO at $10 per unit, with $361M net proceeds
Filed July 31, 2026 · ~1 min read
Key Changes
-
high
The SPAC is offering 36,000,000 units at $10.00 each, with $360.0M placed in trust for a future business combination.
The Offering verify on EDGAR → -
high
Net proceeds to the company are $361M, including $3.5M from private placement units; $360M goes into the trust account.
Use of Proceeds verify on EDGAR → -
high
Public shareholders face dilution ranging from 28.5% to 111.97% depending on redemptions and over-allotment.
Dilution verify on EDGAR →
3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FPS 10-K) is open in full — no account needed.
Partner
Trade XIII commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify